95
Participants
Start Date
May 31, 2005
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets
1 tablet daily by mouth
Placebo tablet
1 tablet daily by mouth
Duramed Investigational Site, Pittsburgh
Duramed Investigational Site, Willow Grove
Duramed Investigational Site, Philadelphia
Duramed Investigational Site, Decatur
Duramed Investigational Site, Louisville
Duramed Investigational Site, Columbus
Duramed Investigational Site, Cleveland
Duramed Investigational Site, Cincinnati
Duramed Investigational Site, St Louis
Duramed Investigational Site, Salt Lake City
Duramed Investigational Site, Medford
Duramed Investigational Site, Denver
Duramed Investigational Site, Providence
Lead Sponsor
Duramed Research
INDUSTRY